(3S,5R)-3-Amino-5-hydroxy-piperidine-1-carboxylic acid tert-butyl ester, 98+%, 100mg

METHYL 1-(4-HYDROXYPHENYL)CYCLOPROPANE-1-CARBOXYLATE, 95.0%, 1g

N-(2,5-Dibromo-phenyl)-thioacetamide, 95.0%, 1g

N'-ISOPROPYLISONICOTINOHYDRAZIDE, 97.0%, 1g

1-(Prop-2-yn-1-yl)-2,5-dihydro-1h-pyrrole-2,5-dione, 97%, 1g

5-Bromo-2,3-dihydro-1H-inden-1-amine, 95.0%, 10g

5-ethoxy-4-iodo-1H-pyrazole, 98%, 250mg

tert-Butyl 4-(4-bromo-2-fluorobenzoyl)piperidine-1-carboxylate, 97%, 1g

5-[2(R)-[1(R)-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3(S)-(4-fluorophenyl)morpholin-4-ylmethyl]-3,4-dihydro-2H-1,2,4-triazol-3-one, 98%, 25g

Methyl 3-chloro-4-hydroxybenzoate, 98.0%, 10g

4,4'-Azanediylbis(butan-1-ol), 95.0%, 250mg

Conductivity standard ROTI®Calipure, 10 µS/cm (25 °C), 250 ml, plastic packaging.

2',4',6'-Trihydroxy-2-phenylacetophenone>96.0%(GC)1g